MissionIR Articles
-
Shire (SHPG) Starts Presentation at the Biotech Showcase 2013 Conference
Shire is a biopharmaceutical company that focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas. SHPG’s in-licensing, merger and acquisition…
-
Organovo Holdings Inc. (ONVO) Starts Presentation at the Biotech Showcase 2013 Conference
Organovo Holdings focuses on breakthrough 3D biology capabilities to create tissue on-demand for research and surgical applications. The company’s NovoGen MMX Bioprinter™ is the world’s only commercial bioprinter with the proven ability to create tissue.…
-
Resverlogix Corp. (RVXCF) Starts Presentation at the Biotech Showcase 2013 Conference
Resverlogix is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is developing RVX-208 for the treatment of atherosclerosis. RVX’s business model is to seek strategic opportunities through…
-
Amarantus Bioscience, Inc. (AMBS) Starts Presentation at the OneMedForum 2013 Conference
Amarantus Bioscience is a development-stage biotechnology company focused on developing certain biologics surrounding its intellectual property and proprietary technologies for treating and/or diagnosing Parkinson’s disease, traumatic brain injury and other human diseases. Amarantus owns the…
-
Oragenics, Inc. (OGEN) Starts Presentation at the OneMedForum 2013 Conference
Oragenics is dedicated to becoming a global leader in probiotics for oral health in humans and pets and in novel antibiotics against infectious disease. The company is engaged in developing, marketing and selling proprietary probiotics…
-
ZBB Energy Corp. (ZBB) Secures Order for Grid Independent ZBB EnerSystem with University of Technology Sydney
ZBB Energy, the developer of cutting-edge electrical power management platform architectures that fit the growing global need for distributed renewable energy, energy efficiency, power quality, and ultimately grid modernization, reported today that the company has…
-
NeuroMetrix, Inc. (NURO) Starts Presentation at the OneMedForum 2013 Conference
NeuroMetrix is an innovative medical device company focused on developing and marketing home use and point-of-care devices, associated consumables and support software for treating and managing diabetes and its complications. Nerve-related complications of diabetes, or…
-
Cytori Therapeutics Inc. (CYTX) Starts Presentation at the Biotech Showcase 2013 Conference
Cytori Therapeutics is a medical technologies company focused on the potential of adult stem cell and regenerative cells from adipose tissue. The company’s Celution® System family of medical devices and instruments is being sold into…
-
Sucampo Pharmaceuticals (SCMP) Starts Presentation at the Biotech Showcase 2013 Conference
Sucampo Pharmaceuticals is a global pharmaceutical company engaged in the development and commercialization of medicines based on prostones, a class of compounds occurring naturally in the body. The company is focused on developing prostone-based compounds…
-
DARA BioSciences, Inc. (DARA) Starts Presentation at the OneMedForum 2013 Conference
DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA…
-
Immunovaccine, Inc. (IMV) Starts Presentation at the OneMedForum 2013 Conference
Immunovaccine is a clinical-stage vaccine development company focused on the advancement of its patented DepoVax vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health. Demonstrating safety and immunogenicity potential, Immunovaccine…
-
Bio-Path Holdings Inc. (BPTH) Starts Presentation at the Biotech Showcase 2013 Conference
Bio-Path Holdings is a biotech company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology, which was designed to systemically distribute nucleic acid drugs throughout the human body via intravenous infusion. BPTH is…
-
CytoSorbents Corporation (CTSO) Starts Presentation at the OneMedForum 2013 Conference
CytoSorbents is a therapeutic device company focused on critical care. The company uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CytoSorbents’ purification technology is based on biocompatible, highly…
-
ReNeuron Group (RNUGF) Starts Presentation at the Biotech Showcase 2013 Conference
ReNeuron Group is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications worldwide. Its lead therapeutic candidate is ReN001 stem cell therapy, which is in clinical development…
-
Inovio Pharmaceuticals Inc. (INO) Starts Presentation at the Biotech Showcase 2013 Conference
Inovio Pharmaceuticals is engaged in the development of synthetic vaccines, with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of universal vaccines capable of providing cross-protection against pathogens, such…
-
FluoroPharma Medical, Inc. (FPMI) Starts Presentation at the OneMedForum 2013 Conference
FluoroPharma Medical is a biopharmaceutical company focused on discovering and developing proprietary PET imaging and products for the evaluation of cardiac disease at the cellular and molecular levels. With licensed technology from the Massachusetts General…
-
Advanced Cell Technology Inc. (ACTC) Starts Presentation at the Biotech Showcase 2013 Conference
Advanced Cell Technology is a biotech company that applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine. ACTC is also developing therapeutic platforms using corneal…
-
Avita Medical Ltd. (AVMXF) Starts Presentation at the Biotech Showcase 2013 Conference
Avita Medical develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The company’s lead product, ReCell® Spray-On Skin™, is CE-marked for Europe, TGA-registered in…
-
MiMedx Group, Inc. (MDXG) Starts Presentation at the OneMedForum 2013 Conference
MiMedx Group is an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants that are processed from human amniotic membrane. The company’s mission is to provide physicians with products and tissues to…
-
Agenus, Inc. (AGEN) Starts Presentation at the OneMedForum 2013 Conference
Agenus is a biotechnology company engaged in developing treatments for cancers and infectious diseases. The company’s focus is on immunotherapeutic products based on strong platform technologies, with multiple product candidates advancing through the clinic, including…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line
- Beeline Holdings Inc. (NASDAQ: BLNE) Partners with TYTL Corp on Tokenized Fractional Real Estate Model
- Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product
- MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Completes Participation In U.S. Army TiC 2.0 Autonomous Breach Event